C-Met immunoreactivity in operated stage I non-small cell lung cancer patients: Is it a prognostic marker?

Journal Title: Ege Tıp Dergisi - Year 2014, Vol 53, Issue 1

Abstract

Aim: In this study we evaluated the correlation between c-Met immunoreactivity and survival, thus the effect of hepatocyte growth factor (HGF) on prognosis, in operated early-stage non-small cell lung carcinoma (NSCLC) patients. Materials and Methods: Seventy patients who underwent resection for stage IA or IB NSCLC were examined retrospectively. Pathological preparations were evaluated to investigate c-Met immunoreactivity. Those with normal bronchial epithelium in the sections were used as positive control group and the sections of those who had not been stained by primary antibody were regarded as the negative control group. C-Met immunoreactivities were determined according to scores of staining. Results: There were no significant differences between c-Met immunoreactivity and clinicopathological factors. The analysis after exclusion of large cell carcinoma cases showed that c-Met immunoreactivity was higher in adenocarcinomas than in squamous cell carcinomas and the difference was statistically significant. Survival analysis to estimate the prognostic significance of c-Met immunoreactivity showed no significant differences for both diseasefree (p=0.499) and long-term survival (p=0.261). The difference between c-Met immunoreactivity and survival for the adenocarcinoma and squamous cell carcinoma groups was not significant. Conclusion: It seems that HGF expression and serum HGF levels appeared to be stronger prognostic markers than c-Met immunoreactivity for NSCLC, therefore detailed studies were needed regarding these prognostic factors.

Authors and Affiliations

A Ozdil, U Cagirici, K Turhan, A G Ergonul

Keywords

Related Articles

Akraba dışı allojenik kök hücre nakli ile başarıyla tedavi edilen primer ileal miyeloid sarkom

Miyeloid sarkom, granülositik sarkom veya kloroma olarak da adlandırılan olgunlaşmamış miyeloid hücre proliferasyonunun ekstramedüller tutulumudur. Miyeloid sarkom olgularının sadece %6,5’i gastrointestinal sistemden kök...

Zoledronik asit uygulamasının meme kanseri hücre hattı (MCF 7) kanser kök hücrelerinin üzerine otofaji gen seviyesindeki etkilerinin araştırılması

Amaç: Zoledronik asit (ZA) uygulanmış meme kanser kök hücrelerinde (KKH), kanser kök hücresi ve otofaji ile ilişkili gen ekspresyonlarındaki farklılıkları incelemek. Gereç ve Yöntem: CD44yüksek/CD24yüksek yüzey belirteçl...

Antiphospholipid antibody associated adrenal hemorrhage causing acute adrenal insufficiency

Arterial or venous thrombosis can be seen in the presence of antiphospholipid antibody. Various pathogenetic mechanisms are put forward in case of antiphospholipid syndrome. Herein a case of 62-year-old male patient who...

Multidisciplinary approach for complicated Fournier gangrene

Fournier gangrene is an infectious disease originates from perineal and gluteal region spreading throughout the fascia. Life threatining results can be seen due to insufficient debridation or delay in treatment. A 23-yea...

Impact of experience on percutaneous nephrolithotomy complications

Aim: Percutaneous nephrolithotomy (PNL) is a minimally invasive surgical procedure which has evolved in technique and instrumentation throughout the years. But just like every surgical procedure, PNL can have several com...

Download PDF file
  • EP ID EP344869
  • DOI 10.19161/etd.344034
  • Views 102
  • Downloads 0

How To Cite

A Ozdil, U Cagirici, K Turhan, A G Ergonul (2014). C-Met immunoreactivity in operated stage I non-small cell lung cancer patients: Is it a prognostic marker?. Ege Tıp Dergisi, 53(1), 13-18. https://europub.co.uk/articles/-A-344869